BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 113103
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.113103
Figure 2
Figure 2 Serum oncological biomarkers in both patient groups. A: Comparative carcinoembryonic antigen levels before and after surgery; B: Preoperative and postoperative cytokeratin 19 fragment antigen 21-1 level variations across groups; C: Carbohydrate antigen 125 variation pre-surgery vs post-surgery. aP < 0.05, bP < 0.01 for within-group vs baseline; cP < 0.05 for inter-group vs four-port. CA125: Carbohydrate antigen 125; CEA: Carcinoembryonic antigen; Cyfra 21-1: Cytokeratin 19 fragment antigen 21-1.


Write to the Help Desk